Literature DB >> 20170397

The polymorphisms -1131T>C and the S19W of the APOA5 gene are not associated with coronary artery disease in a Brazilian population.

Caroline Luise Prochaska1, Geraldo Picheth, Mauren Isfer Anghebem-Oliveira, Costantino Ortiz Costantini, Emanuel Maltempi de Souza, Fábio Oliveira Pedrosa, Marileia Scartezini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20170397     DOI： 10.1515/CCLM.2010.070

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  10 in total

1.  Association of APOA5 Gene Promoter Region -1131T>C Polymorphism (rs662799) to Plasma Triglyceride Level in Patients with Type 2 Diabetic Nephropathy.

Authors:  Abdolkarim Mahrooz; Mehryar Zargari; Vahid Ansari; Atieh Makhlough; Mohammad-Bagher Hashemi-Sooteh
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Analysis of causal effect of APOA5 variants on premature coronary artery disease.

Authors:  Fan Wang; Isabel Z Wang; Stephen Ellis; Stephen Archacki; John Barnard; Carlos Hubbard; Eric J Topol; Qiuyun Chen; Qing K Wang
Journal:  Ann Hum Genet       Date:  2018-07-19       Impact factor: 1.670

3.  -1131T>C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients.

Authors:  Mirelle O Sóter; Karina B Gomes; Ana P Fernandes; Maria das G Carvalho; Poliana S Pinheiro; Adriana A Bosco; Daniel D R Silva; Marinez O Sousa
Journal:  Mol Biol Rep       Date:  2012-02-19       Impact factor: 2.316

4.  Association of c.56C > G (rs3135506) Apolipoprotein A5 Gene Polymorphism with Coronary Artery Disease in Moroccan Subjects: A Case-Control Study and an Updated Meta-Analysis.

Authors:  Imane Morjane; Hicham Charoute; Sanaa Ouatou; Lamiae Elkhattabi; Houda Benrahma; Rachid Saile; Hassan Rouba; Abdelhamid Barakat
Journal:  Cardiol Res Pract       Date:  2020-08-04       Impact factor: 1.866

5.  Association of APOA5 T1131C polymorphism and risk of coronary artery disease.

Authors:  Jing Xia; Weiping Cai; Caosheng Peng
Journal:  Int J Clin Exp Med       Date:  2015-06-15

6.  Apolipoprotein A5 gene polymorphism (rs662799) and cardiovascular disease in end-stage kidney disease patients.

Authors:  Jerry Jacob; Sylwia Boczkowska; Wojciech Zaluska; Monika Buraczynska
Journal:  BMC Nephrol       Date:  2022-09-07       Impact factor: 2.585

7.  Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.

Authors:  Guang Yang; Ming-Ming Lei; Chun-Lei Yu; Xiao-Xiao Liu; Zhe An; Chun-Li Song
Journal:  Lipids Health Dis       Date:  2015-09-19       Impact factor: 3.876

8.  Positive Association between APOA5 rs662799 Polymorphism and Coronary Heart Disease: A Case-Control Study and Meta-Analysis.

Authors:  Huadan Ye; Annan Zhou; Qiangxiao Hong; Linlin Tang; Xuting Xu; Yanfei Xin; Danjie Jiang; Dongjun Dai; Yirun Li; Dao Wen Wang; Shiwei Duan
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

9.  Apolipoprotein A5 gene variants and the risk of coronary heart disease: a case‑control study and meta‑analysis.

Authors:  Jianqing Zhou; Limin Xu; Rong Stephanie Huang; Yi Huang; Yanping Le; Danjie Jiang; Xi Yang; Weifeng Xu; Xiaoyan Huang; Changzheng Dong; Meng Ye; Jiangfang Lian; Shiwei Duan
Journal:  Mol Med Rep       Date:  2013-08-16       Impact factor: 2.952

10.  Association of G894T eNOS, 4G/5G PAI and T1131C APOA5 polymorphisms with susceptibility to myocardial infarction in Morocco.

Authors:  Hind Hassani Idrissi; Wiam Hmimech; Brehima Diakite; Farah Korchi; Dalila Baghdadi; Rachida Habbal; Sellama Nadifi
Journal:  Meta Gene       Date:  2016-04-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.